Article
Telomere status in chronic lymphocytic leukemia with TP53 disruption.
Oncotarget - 30 Aug 2016
Guièze Romain, Pages Mélanie, Véronèse Lauren, Combes Patricia, Lemal Richard, Gay-Bellile Mathilde, Chauvet Martine, Callanan Mary, Kwiatkowski Fabrice, Pereira Bruno, Vago Philippe, Bay Jacques-Olivier, Tournilhac Olivier, Tchirkov Andreï
Abstract excerpt
In chronic lymphocytic leukemia (CLL), telomere dysfunction is associated with poor outcomes. TP53 is involved in cellular responses to dysfunctional telomeres, and its inactivation is the strongest adverse prognostic factor for CLL. Given the biological relationship between TP53 and telomeres, and their prognostic value, it is important to improve our understanding of the impact of TP53 alterations on telomeres....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
